Testing effectiveness (Phase 2)Study completedNCT00944684What this trial is testingHigh Dose Ribavirin in the Treatment of Chronic Hepatitis CWho this might be right forChronic Hepatitis C University of Bern 32
Not applicableNot Yet RecruitingNCT06872047What this trial is testingExploring the Knowledge, Attitudes, Behaviors and Perceived Barriers of Hepatologists Towards Non-invasive Hepatocellular Carcinoma Prediction Models in Hepatitis C Patients Who Achieved Sustained Virological Response Following Direct Acting Antivirals TherapyWho this might be right forNon-invasive Hepatocellular Carcinoma Assiut University 400
Not applicableStudy completedNCT03659058What this trial is testingImpact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVRWho this might be right forFibrosis, Liver Zagazig University 400
Post-approval studies (Phase 4)UnknownNCT02008214What this trial is testingEfficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV PatientsWho this might be right forHepacivirusHIV Infections Centro Universitario de Ciencias de la Salud, Mexico 60
Not applicableStudy completedNCT04577482What this trial is testingStudy of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological ResponseWho this might be right forHepatitis C Virus (HCV) AbbVie 42
Post-approval studies (Phase 4)Study completedNCT00630084What this trial is testingPeginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular CarcinomaWho this might be right forChronic Hepatitis CNeoplasms Kaohsiung Medical University Chung-Ho Memorial Hospital 120
Large-scale testing (Phase 3)Study completedNCT02472886What this trial is testingSafety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV InfectionWho this might be right forHepatitis C Virus Infection Gilead Sciences 153
Not applicableUnknownNCT03591783What this trial is testingImpact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Related Liver DiseaseWho this might be right forHepatitis c Assiut University 140
Not applicableStudy completedNCT02851069What this trial is testingReal World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in ColombiaWho this might be right forChronic Hepatitis C AbbVie 66
Not applicableStudy completedNCT03581383What this trial is testingCommunity Access, Retention in Care, and Engagement for Hepatitis C TreatmentWho this might be right forHepatitis C Jens Rosenau 657
Not applicableUnknownNCT02772744What this trial is testingDetermining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4Who this might be right forHepatitis C Zagazig University 250
Post-approval studies (Phase 4)UnknownNCT01056172What this trial is testingPegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)Who this might be right forChronic Hepatitis C Pusan National University Yangsan Hospital 164
Not applicableUnknownNCT01151397What this trial is testingDoes 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?Who this might be right forChronic Hepatitis C Ziv Hospital 60
Large-scale testing (Phase 3)Study completedNCT03212521What this trial is testingEfficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1Who this might be right forHepatitis C Virus (HCV) AbbVie 230
Very early researchUnknownNCT03882307What this trial is testingLevels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients SeraWho this might be right forHepatitis C, Chronic Assiut University 40
Testing effectiveness (Phase 2)Study completedNCT00901524What this trial is testingANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIVWho this might be right forHepatitis ANRS, Emerging Infectious Diseases 58
Testing effectiveness (Phase 2)Study completedNCT01271790What this trial is testingResponse-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Gilead Sciences 245
Not applicableStudy completedNCT03002818What this trial is testingQuality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)Who this might be right forChronic Hepatitis C Virus (HCV) AbbVie 41
Post-approval studies (Phase 4)Study completedNCT00629824What this trial is testingPegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis CWho this might be right forChronic Hepatitis C Kaohsiung Medical University Chung-Ho Memorial Hospital 250
Not applicableStudy completedNCT00788918What this trial is testingStudy of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)Who this might be right forHepatitis C, ChronicCognition DisordersFatigue Syndrome, Chronic+1 more Aarhus University Hospital 100